Valproate
Valproate is a pharmaceutical drug with 39 clinical trials. Currently 2 active trials ongoing. Historical success rate of 92.6%.
Success Metrics
Based on 25 completed trials
Phase Distribution
Phase Distribution
9
Early Stage
3
Mid Stage
20
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.2%
25 of 29 finished
13.8%
4 ended early
2
trials recruiting
39
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy
Valproate for the Treatment of Residual Amblyopia
Zolmitriptane as Prophylaxis for Chilhood Migraine
Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium
Clinical Trials (39)
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy
Valproate for the Treatment of Residual Amblyopia
Zolmitriptane as Prophylaxis for Chilhood Migraine
Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium
A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures
Drug-drug Interaction Between Ciprofol and Mefanamic Acid or Valproate
ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness
Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures
Sleep Architecture in Valproate-induced Nocturnal Enuresis in Primary School and Preschool Children.
Determining Metabolic Effects of Valproate and Antipsychotic Therapy
Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus
Valproate Versus Ketorolac Versus Metoclopramide
Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell Lymphoma
Cytidine- and Creatine-Containing Drug in Treating Bipolar Depression
Antiepileptic Drugs and Vascular Risk Markers
Assessment of Valproate on Ethanol Withdrawal
Decision-Making in Bipolar Disorder
Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
Pretreatment With Valproate Prior to Immunotherapy Targeting Cluster of Differentiation Antigen 20 in Chronic Lymphocytic Leukemia
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 39